Paper907657
Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry.
LeRoy AF and 9 others. Biochem Med, 1977. Cited by 235 papers, by iCite.
Cite this record
ConductScience Library. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Papers, record 907657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/907657
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Platinum | Major topic |
| Animals | |
| Cisplatin | |
| Dogs | |
| Humans | |
| Spectrophotometry, Atomic | |
| Tissue Distribution |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 235 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41379234 | Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy. | Cancer Chemother Pharmacol | 2025 | https://conductscience.org/library/papers/41379234 | PubMed |
| 36892677 | Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer. | Cancer Chemother Pharmacol | 2023 | https://conductscience.org/library/papers/36892677 | PubMed |
| 33675184 | Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors. | Cancer Med | 2021 | https://conductscience.org/library/papers/33675184 | PubMed |
| 29725440 | Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29725440 | PubMed |
| 27446541 | Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report. | Biomed Rep | 2016 | https://conductscience.org/library/papers/27446541 | PubMed |
| 27393140 | Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study. | Clin Pharmacokinet | 2017 | https://conductscience.org/library/papers/27393140 | PubMed |
| 26225053 | Superselective Intra-arterial Infusion Chemotherapy with Nedaplatin for Oral Cancer: A Pharmacological Study of the Dose Clearance. | J Maxillofac Oral Surg | 2015 | https://conductscience.org/library/papers/26225053 | PubMed |
| 23287530 | Vitamin B6 metabolism influences the intracellular accumulation of cisplatin. | Cell Cycle | 2013 | https://conductscience.org/library/papers/23287530 | PubMed |
| 22966334 | Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis. | Oncol Lett | 2010 | https://conductscience.org/library/papers/22966334 | PubMed |
| 20191372 | Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1. | J Biol Inorg Chem | 2010 | https://conductscience.org/library/papers/20191372 | PubMed |
| 16683074 | A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors. | Invest New Drugs | 2006 | https://conductscience.org/library/papers/16683074 | PubMed |
| 16372828 | Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/16372828 | PubMed |
| 16369746 | Phase I study of cisplatin and irinotecan combined with concurrent hyperfractionated accelerated thoracic radiotherapy for locally advanced non-small cell lung carcinoma. | Int J Clin Oncol | 2005 | https://conductscience.org/library/papers/16369746 | PubMed |
| 16222320 | A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies. | Br J Cancer | 2005 | https://conductscience.org/library/papers/16222320 | PubMed |
| 15151521 | Population pharmacokinetics of total and unbound plasma cisplatin in adult patients. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/15151521 | PubMed |
| 12556954 | Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer. | Br J Cancer | 2003 | https://conductscience.org/library/papers/12556954 | PubMed |
| 11714450 | Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin. | Jpn J Cancer Res | 2001 | https://conductscience.org/library/papers/11714450 | PubMed |
| 10668856 | Oxaliplatin: pharmacokinetics and chronopharmacological aspects. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10668856 | PubMed |
| 9376268 | Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9376268 | PubMed |
| 8630273 | Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice. | Br J Cancer | 1996 | https://conductscience.org/library/papers/8630273 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/907657
GET https://conductscience.org/api/papers/v1/907657/cited_by?page=2